1Slingluff CL,Jr.Tumor antigens and tumor vaccines: peptides as immunogens[].Seminars in Surgical Oncology.1996 被引量：1
2Gilboa E.The makings of a tumor rejection antigen[].Immunity.1999 被引量：1
3Raposo G,Nijman HW,Stoorvogel W, et al.B lymphocytes secrete antigen-presenting vesicles[].The Journal of Experimental Medicine.1996 被引量：1
4Li M,Davey GM,Sutherland RM, et al.Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo[].J Immunol.2001 被引量：1
5Jung S,Unutmaz D,Wong P, et al.In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens[].Immunity.2002 被引量：1
6Old LJ.Cancer immunology: the search for specificity-G H. A. Clowes Memorial lecture[].Cancer Research.1981 被引量：1
7Utsugi-Kobukai S,Fujimaki H,Hotta C,Nakazawa M,Minami M.MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells[].Immunology Letters.2003 被引量：1
8Xiang J,Huang H,Liu Y.A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells[].J Immunol.2005 被引量：1
9Banchereau J,Schuler-Thurner B,Palucka AK,Schuler G.Dendritic cells as vectors for therapy[].Cell.2001 被引量：1
10Lenschow DJ,Walunas TL,Bluestone JA.CD28/B7 system of Tcell costimulation[].Annual Review of Immunology.1996 被引量：1
4Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy [J]. Technol Cancer Res Treat, 2005, 4 (4) : 363-374. 被引量：1
5Ribas A, Butterfield LH, Glaspy JA, et al. Current developments in cancer vaccines and cellular immunotherapy [J]. J Clin Oncol, 2003, 21 (12) : 2415-2432. 被引量：1
6Scanlan MJ, Simpson A, Old LJ. The cancer/testis genes: review, standardization, and commentary [J]. Cancer Immun, 2004,4(1): 1-15. 被引量：1
7van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic t lymphocytes on a human melanoma [J]. Science, 1991, 254 (5038): 1643-1647. 被引量：1
8Caballero OL, Chen YT. Cancer/testis (ct) antigens: potential targets for immunotherapy [J]. Cancer Sci, 2009, 100 (11) : 2014-2021. 被引量：1
9Eliyahu D, Michalovitz D, Oren M. Overproduction of p53 antigen makes established cells highly tumorigenic [J]. 1985, 316 (6024) : 158-160. 被引量：1
10Ross JS, Fletcher JA. The her-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy EJ]. Stem Cells, 1998, 16 (6): 413-428. 被引量：1
